Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non-Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations.

Robert Donald Harvey Suanna Steeby BruinoogeLi ChenElizabeth Garrett-MayerWhitney RhodesEdward StepanskiThomas S UldrickGwynn IsonSean KhozinWendy S Rubinstein Caroline Schenkel Robert S Miller George A Komatsoulis Richard L SchilskyEdward S Kim

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

This analysis of real-world data demonstrated that broadening three common eligibility criteria has the potential to double the eligible patient population and include trial participants who are more representative of those encountered in practice.See related commentary by Giantonio, p. 2369.

Keyphrases

advanced non small cell lung cancer
phase iii
study protocol
epidermal growth factor receptor
phase ii
clinical trial
healthcare
primary care
case report
electronic health record
open label
big data
quality improvement
machine learning
human health
risk assessment
artificial intelligence
data analysis